Cargando…

Problematic Analysis and Inadequate Toxicity Data in Phase III Apatinib Trial in Gastric Cancer

Detalles Bibliográficos
Autor principal:	Zhang, Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2016
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477931/ https://www.ncbi.nlm.nih.gov/pubmed/27528723 http://dx.doi.org/10.1200/JCO.2016.67.3889

Ejemplares similares

Is Treatment-Emergent Toxicity a Biomarker of Efficacy of Apatinib in Gastric Cancer?
por: Lee, Hyo Jin, et al.
Publicado: (2016)

Inadequate Evidence to Support Phase III Studies of Albumin in Severe Malaria
por: Woodrow, Charles J, et al.
Publicado: (2007)

Apatinib in Advanced Gastric Cancer: A Doubtful Step Forward
por: Fornaro, Lorenzo, et al.
Publicado: (2016)

Gastric cancer: predictors of recurrence when lymph-node dissection is inadequate
por: Uña, Esther
Publicado: (2009)

False reassurance or inadequate drug levels?
por: Tirlangi, Praveen, et al.
Publicado: (2020)

Prostate cancer and hypofractionation: reflections on recent randomised phase III clinical trial results
por: Dearnaley, David, et al.
Publicado: (2017)

Outcome measures of phase III anticancer drug trials in China
por: Guo, Lanwei, et al.
Publicado: (2023)

Claiming “New” in What Might be an Inadequate Search
por: Acién, Maribel, et al.
Publicado: (2015)

Phase III Trial of Albumin in Malaria Still Lacks Scientific Justification
por: Woodrow, Charles J, et al.
Publicado: (2007)

Immunotherapy in patients with metastatic castration-resistant prostate cancer: a meta-analysis of data from 7 phase III studies and 3 phase II studies
por: Zhang, Anqiang, et al.
Publicado: (2022)

Respiratory research funding is inadequate, inequitable, and a missed opportunity
por: Williams, Siân, et al.
Publicado: (2020)

The data management of a phase III efficacy trial of an 11-valent pneumococcal conjugate vaccine and related satellite studies conducted in the Philippines
por: Sanvictores, Diozele Hazel M, et al.
Publicado: (2012)

Improvement of atopic dermatitis with dupilumab occurs equally well across different anatomical regions: data from phase III clinical trials
por: Blauvelt, A., et al.
Publicado: (2019)

Apatinib treatment for unresectable gastrointestinal stromal tumor with synchronous gastric cancer
por: Xu, Huanji, et al.
Publicado: (2020)

‘No research without perfect methods’: a problematic approach in epidemiology
por: Wuopio, Jonas, et al.
Publicado: (2023)

Inadequate study designs for the evaluation of blood pressure monitoring devices and their potential misleading conclusions
por: Almeida, Tiago P., et al.
Publicado: (2023)

Phase III Trials Required to Resolve Clinical Equipoise over Optimal Fluid Management in Children with Severe Malaria
por: Maitland, Kathryn, et al.
Publicado: (2007)

Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial
por: Bucci, Enrico M, et al.
Publicado: (2021)

Apatinib enhances chemosensitivity of gastric cancer to paclitaxel and 5-fluorouracil
por: Xu, Zhiyuan, et al.
Publicado: (2019)

Efficacy and safety of apatinib for the treatment of AFP-producing gastric cancer
por: Li, Ningning, et al.
Publicado: (2020)

Treatment-related toxicities of apatinib in solid tumors: a meta-analysis
por: Peng, Ling, et al.
Publicado: (2018)

The contribution of itch and skin severity improvements to the Dermatology Life Quality Index in patients with atopic dermatitis in baricitinib phase III trials
por: Yosipovitch, Gil, et al.
Publicado: (2022)

The combination of apatinib and S-1 for the treatment of advanced gastric cancer in China: A meta-analysis of randomized controlled trials
por: Liu, Yan, et al.
Publicado: (2018)

Problematic internet usage among children in the new normal digital age: A kaleidoscopic view
por: Menon, Vikas, et al.
Publicado: (2021)

Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial – Authors' reply
por: Logunov, Denis Y, et al.
Publicado: (2021)

Multicenter phase II study of apatinib treatment for metastatic gastric cancer after failure of second-line chemotherapy
por: Ruan, Hanguang, et al.
Publicado: (2017)

Efficacy and safety assessment of apatinib in patients with advanced gastric cancer: a meta-analysis
por: Chen, Jianxin, et al.
Publicado: (2018)

Meta-Analysis of Efficacy and Safety of Karelizumab Combined with Apatinib in the Treatment of Advanced Gastric Cancer
por: Liu, Haipeng, et al.
Publicado: (2022)

Combined aspirin and apatinib treatment suppresses gastric cancer cell proliferation
por: Zhang, Wei, et al.
Publicado: (2017)

Apatinib combined with S-1 as second-line therapy in advanced gastric cancer
por: Qiu, Zhi-Yuan, et al.
Publicado: (2021)

Deception in Research Is Morally Problematic … and so too Is Not Using It Morally: Reply to Open Peer Commentaries on “The Use of Deception in Public Health Behavioral Intervention Trials: A Case Study of Three Online Alcohol Trials”
por: McCambridge, Jim, et al.
Publicado: (2014)

Safety Analysis of Apatinib Combined with Chemotherapy in the Treatment of Advanced Gastric Carcinoma: A Randomised Controlled Trial
por: Yuan, Min, et al.
Publicado: (2021)

Effectiveness and Safety of Apatinib Plus Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer: A Nonrandomized Controlled Trial
por: Lin, Jian-Xian, et al.
Publicado: (2021)

Phase II trial of VEGFR2 inhibitor apatinib for metastatic sarcoma: focus on efficacy and safety
por: Liao, Zhichao, et al.
Publicado: (2019)

Long-term survival of patients with stage II and III gastric cancer who underwent gastrectomy with inadequate nodal assessment
por: Desiderio, Jacopo, et al.
Publicado: (2021)

Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial
por: Combe, Bernard, et al.
Publicado: (2021)

Identification of gastric microbiota biomarker for gastric cancer
por: Dang, Yi-Ni, et al.
Publicado: (2020)

DUSP1 induces apatinib resistance by activating the MAPK pathway in gastric cancer
por: Teng, Fei, et al.
Publicado: (2018)

Preoperative chemoradiation-induced hematological toxicity and related vertebral dosimetry evaluations in patients with locally advanced gastric cancer: data from a phase III clinical trial
por: Wang, Ji-jin, et al.
Publicado: (2023)

Phase 1 trial of apatinib combined with intensity-modulated radiotherapy in unresectable hepatocellular carcinoma
por: Wang, Hongzhi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fj80k9u8pcmjuc3n0vgm97fgia